The impact of coding germline variants on contralateral breast cancer risk and survival

Anna Morra , Nasim Mavaddat , Taru A Muranen , Thomas U Ahearn
The American Journal of Human Genetics 110 ( 3) 475 -486

7
2023
Association of the CHEK2 c. 1100delC variant, radiotherapy, and systemic treatment with contralateral breast cancer risk and breast cancer‐specific survival

Anna Morra , Maartje AC Schreurs , Irene L Andrulis , Hoda Anton‐Culver
Cancer medicine 12 ( 15) 16142 -16162

2023
C-KIT MUTATIONS ARE A RELATIVELY FREQUENT EVENT IN PROGRESSION OF AML M2

A BEGHINI , R CAIROLI , P PETERLONGO , C RIPAMONTI
HAEMATOLOGICA-PAVIA THEN ROMA- 84 ( 9; SUPP/1) 14 -14

1999
Polygenic risk scores and breast and epithelial ovarian cancer risks for carriers of BRCA1 and BRCA2 pathogenic variants.

Daniel R Barnes , Matti A Rookus , Lesley McGuffog , Goska Leslie
Genetics in Medicine 22 ( 10) 1653 -1666

9
2020
Common Genetic Variants and Modification of Penetrance of BRCA2-Associated Breast Cancer

Mia M Gaudet , Tomas Kirchhoff , Todd Green , Joseph Vijai
PLoS

2010
Genetic variation in mitotic regulatory pathway genes is associated with breast tumor grade | NOVA. The University of Newcastle's Digital Repository

Seth Slettedahl , V. Shane Pankratz , Alison M. Dunning , Kristen S. Purrington
Oxford University Press

2014
Breast cancer risk genes - Association analysis in more than 113,000 women

Breast Cancer Association Consortium ,
The New England Journal of Medicine 384 ( 5) 428 -439

124
2021
CYP3A7*1C allele: linking premenopausal oestrone and progesterone levels with risk of hormone receptor-positive breast cancers.

Nichola Johnson , Sarah Maguire , Anna Morra , Pooja Middha Kapoor
British Journal of Cancer 124 ( 4) 842 -854

2021
1
2021
Detecting Variants in the NBN Gene While Testing for Hereditary Breast Cancer: What to Do Next?

Irene Catucci , Laura Cortesi , Michele Vidone , Marco Sazzini
International Journal of Molecular Sciences 22 ( 11)

2021
Confirmation of 5p12 As a Susceptibility Locus for Progesterone-Receptor–Positive, Lower Grade Breast Cancer

Roger L. Milne , Ellen L. Goode , Montserrat García-Closas , Fergus J. Couch
Cancer Epidemiology, Biomarkers & Prevention 20 ( 10) 2222 -2231

28
2011
Whole-exome sequencing and targeted gene sequencing provide insights into the role of PALB2 as a male breast cancer susceptibility gene.

Valentina Silvestri , Veronica Zelli , Virginia Valentini , Piera Rizzolo
Cancer 123 ( 2) 210 -218

20
2017
C-kit mutations in core binding factor leukemias.

Alessandro Beghini , Paolo Peterlongo , Carla B. Ripamonti , Lidia Larizza
Blood 95 ( 2) 726 -728

297
2000
Evaluation of CYP17A1 and CYP1B1 polymorphisms in male breast cancer risk.

Piera Rizzolo , Valentina Silvestri , Virginia Valentini , Veronica Zelli
Endocrine connections 8 ( 8) 1224 -1229

1
2019
Colorectal cancer risk in individuals with biallelic or monoallelic mutations of MYH

Paolo Peterlongo , Nandita Mitra , Shaokun Chuai , Tomas Kirchhoff
International Journal of Cancer 114 ( 3) 505 -507

55
2005
TGFBR1*6A may contribute to hereditary colorectal cancer.

Yansong Bian , Trinidad Caldes , Juul Wijnen , Patrick Franken
Journal of Clinical Oncology 23 ( 13) 3074 -3078

45
2005
TGFBR1*6A and cancer: a meta-analysis of 12 case-control studies.

Boris Pasche , Virginia Kaklamani , Nanjiang Hou , Taya Young
Journal of Clinical Oncology 22 ( 4) 756 -758

83
2004
Association between CASP8 –652 6N Del Polymorphism (rs3834129) and Colorectal Cancer Risk: Results from a Multi-Centric Study

Barbara Pardini , Paolo Verderio , Sara Pizzamiglio , Carmela Nici
PLoS ONE 9 ( 1) e85538

4
2014
Interplay between BRCA1 and RHAMM Regulates Epithelial Apicobasal Polarization and May Influence Risk of Breast Cancer

Christopher A Maxwell , Javier Benítez , Laia Gómez-Baldó , Ana Osorio
PLoS Biology 9 ( 11) e1001199 -18

161
2011